Hernandez-Guzman F G, Higashiyama T, Osawa Y, Ghosh D
Department of Molecular and Cellular Biophysics, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.
J Steroid Biochem Mol Biol. 2001 Nov;78(5):441-50. doi: 10.1016/s0960-0760(01)00119-4.
Estrone (E1)/dehydroepiandrosterone (DHEA) sulfatase (ES/DHEAS) catalyzes the hydrolysis of E1 and DHEA-sulfates releasing unconjugated steroids. ES is a component of the three-enzyme system that has been implicated in intracrine biosynthesis of estradiol, hence, proliferation of hormone dependent breast tumors. ES is bound to the membrane of the endoplasmic reticulum, presumably through multiple transmembrane and other membrane anchoring segments. The highly hydrophobic nature of the enzyme has so far prevented its purification to homogeneity in quantities sufficient for crystallization. We report here the purification, biochemical characterization and crystallization of the full-length, active form of the enzyme from the membrane bound fraction of human placenta. Our results demonstrate that the key to successful purification and growth of diffraction quality crystals of this difficult membrane bound enzyme is the exploitation of optimal solubilization and detergent conditions to protect the structural and functional integrity of the molecule, thereby preventing nonspecific aggregation and other instabilities. This work paves the way for the first structural study of a membrane bound human sulfatase and subsequent rational design of inhibitors for use as anti-tumor agents.
雌酮(E1)/脱氢表雄酮(DHEA)硫酸酯酶(ES/DHEAS)催化E1和硫酸脱氢表雄酮的水解,释放出未结合的甾体。ES是参与雌二醇内分泌生物合成的三酶系统的一个组成部分,因此与激素依赖性乳腺肿瘤的增殖有关。ES与内质网膜结合,大概是通过多个跨膜和其他膜锚定片段。迄今为止,该酶高度疏水的性质阻碍了其以足以结晶的量纯化至均一状态。我们在此报告了从人胎盘膜结合部分纯化该酶的全长活性形式、进行生化表征及结晶的过程。我们的结果表明,成功纯化并生长出这种难以处理的膜结合酶的衍射质量晶体的关键在于利用最佳的增溶和去污剂条件来保护分子的结构和功能完整性,从而防止非特异性聚集和其他不稳定性。这项工作为首次对膜结合人硫酸酯酶进行结构研究以及随后合理设计用作抗肿瘤药物的抑制剂铺平了道路。